Low papanicolaou smear screening rate of women with hiv infection: A nationwide population-based study in Taiwan, 2000-2010

Journal of Women's Health

Volumn 22, Issue 12, 2013, Pages 1016-1022

  Chen, Yen Chin ^a   Liu, Hsiao Ying ^a   Li, Chung Yi ^b   Lee, Nan Yao ^c   Ko, Wen Chien ^c   Chou, Cheng Yang ^d   Hsieh, Tung Han ^c   Ko, Nai Ying ^a,b  

^a Departments of Nursing   (United States)

^b Departments of Public Health   (United States)

^c Departments of Medicine   (United States)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCOME; MAJOR CLINICAL STUDY; MEDICAL HISTORY; OPPORTUNISTIC INFECTION; PAPANICOLAOU TEST; PRIORITY JOURNAL; SCREENING TEST; SEXUALLY TRANSMITTED DISEASE; TAIWAN;

ADOLESCENT; ADULT; AGED; AMBULATORY CARE FACILITIES; EARLY DETECTION OF CANCER; FEMALE; HIV INFECTIONS; HUMANS; LOGISTIC MODELS; MASS SCREENING; MIDDLE AGED; PAPANICOLAOU TEST; POPULATION SURVEILLANCE; PREVALENCE; RETROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS; TAIWAN; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 84888869471     PISSN: 15409996     EISSN: 1931843X     Source Type: Journal    
DOI: 10.1089/jwh.2012.4127     Document Type: Article

References (34)

1. United Nations Programme on HIV/AIDS. AIDS epidemic update. Available at: http://www.unaids.org/en/data analysis/epidemiology/Retrieved March 10, 2012.
2. United Nations Programme on HIV/AIDS. UNAIDS report on the global AIDS epidemic 2010. Available at: http://www.unaids.org/globalreport/global-report. htm Retrieved January 18, 2012.
3. Yang CH, Yang SY, Shen MH, Kuo HS. The changing epidemiology of prevalent diagnosed HIV infections in Taiwan, 1984-2005. Int J Drug Policy. 2008;19:317-323.
4. Taiwan Centers for Disease Control. Updated HIV/AIDS statistics in Taiwan. Available at: http://www.cdc.gov.tw/ch/ShowTopicText.ASP?TopicID = 416 5.
5. Frisch M, Biggar RJ, Engels EA, Goedert JJ. Association of cancer with AIDS-related immunosuppression in adults. JAMA 2001 285 1736-1745
6. Maiman M, Fruchter RG, Clark M, Arrastia CD, Matthews R, Gates EJ. Cervical cancer as an AIDS-defining illness. Obstet Gynecol. 1997;89:76-80.
7. Ellerbrock TV, Chiasson MA, Bush TJ, et al. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA. 2000;283:1031-1037.
8. Holmes RS, Hawes SE, Toure P, et al. HIV infection as a risk factor for cervical cancer and cervical intraepithelial neoplasia in Senegal. Cancer Epidemiol Biomarkers Prev. 2009; 18:2442-2446.
9. Anastos K, Hoover DR, Burk RD, et al. Risk factors for cervical precancer and cancer in HIV-infected, HPV-positive Rwandan women. PLoS One. 2010;5:e13525.
10. Branca M, Garbuglia AR, Benedetto A, et al. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up. Int J STD AIDS. 2003;14:417-425.
11. Chen MJ, Wu MY, Yang JH, Chao KH, Yang YS, Ho HN. Increased frequency of genital human papillomavirus infection in human immunodeficiency virus-seropositive Taiwanese women. J Formos Med Assoc. 2005;104:34-38.
12. Fruchter RG, Maiman M, Sedlis A, Bartley L, Camilien L, Arrastia CD. Multiple recurrences of cervical intraepithelial neoplasia in women with the human immunodeficiency virus. Obstet Gynecol. 1996;87:338-344.
13. Anderson JR, Paramsothy P, Heilig C, Jamieson DJ, Shah K, Duerr A. Accuracy of Papanicolaou test among HIV-infected women. Clinical infectious diseases: An official publication of the Infectious Diseases Society of America 2006;42: 562-568.
14. Kaplan JE, Benson C, Holmes KH, Brooks JT, Pau A, Masur H. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV medicine association of the infectious diseases society of America. MMWR Recomm Rep. 2009; 58:1-207.
15. Oster AM, Sullivan PS, Blair JM. Prevalence of cervical cancer screening of HIV-infected women in the United States. J Acquir Immune Defic Syndr. 2009;51:430-436.
16. Taiwan Burean of Health Promotion. Annual cervical cancer screening report, 2004-2008. Available at: http://www.bhp.doh.gov.tw/bhpnet/portal/ StatisticsShow.aspx?No = 201003110001 Retrieved October 4, 2010.
17. Taiwan Center for Disease Control. Guidelines for diagnosis and treatment of HIV/AIDS. Taipei: Department of Health, Center for Disease Control; 2010.
18. Bureau of National Health Insurance. National health insurance profile 2012. Available at: http://http://nhird.nhri.org.tw/date-01.htm Retrieved October 20, 2011.
19. Huang KH, Tsai WC, Kung PT. The use of Pap smear and its influencing factors among women with disabilities in Taiwan. Res Dev Disabil. 2012;33(2):307-314.
20. Chung SD, Pfeiffer S, Lin HC. Lower utilization of cervical cancer screening by nurses in Taiwan: A nationwide population-based study. Prev Med. 2011;53(1-2):82-84.
21. Liu CY, Hung YT, Chuang YL, Chen YJ, Weng WS, Liu JS. Incorporating development stratification of Taiwan townships into sampling design of large scale health interview survey. J Health Manag. 2006;4:e22.
22. Dombrowski JC, Kent JB, Buskin SE, Stekler JD, Golden MR. Population-based metrics for the timing of HIV diagnosis, engagement in HIV care, and virologic suppression. J Acquir Immune Defic Syndr. 2012;26:77-86.
23. Dal Maso L, Franceschi S, Lise M, et al. Self-reported history of Pap-smear in HIV-positive women in Northern Italy: A cross-sectional study. BMC Cancer. 2010;10:310.
24. Rahangdale L, Sarnquist C, Yavari A, Blumenthal P, Israelski D. Frequency of cervical cancer and breast cancer screening in HIV-infected women in a county-based HIV clinic in the western United States. J Women's Health. 2010;19(4):709-712.
25. Lu M, Moritz S, Lorenzetti D, Sykes L, Straus S, Quan H. A systematic review of interventions to increase breast and cervical cancer screening uptake among Asian women. BMC Public Health. 2012;12:413.
26. Logan JL, Khambaty MQ, D'Souza KM, Menezes LJ. Cervical cancer screening among HIV-infected women in a health department setting. AIDS Patient Care STDS. 2010; 24(8):471-475.
27. Ibrahim FW, Schembri G, Taha H, Ariyanayagam S, Dhar J. Cervical surveillance in HIV-positive women: A genitourinary medicine clinic experience. J Fam Plann Reprod Health Care. 2009;35(2):101-103.
28. Lin HS, Wang LH, Liu SM, Kang CC. Factors associated with Papanicolaou smear practice in women in the Pingtung area. Taiwan J Public Health. 2003;22:127-133.
29. Lee TS, Fu LA, Fleming P. Using focus groups to investigate the educational needs of female injecting heroin users in Taiwan in relation to HIV/AIDS prevention. Health Educ Res. 2006;21(1):55-65.
30. Keiser O, de Tejada BM, Wunder D, et al. Frequency of gynecologic follow-up and cervical cancer screening in the Swiss HIV cohort study. J Acquir Immune Defic Syndr. 2006; 43:550-555.
31. Tello MA, Yeh HC, Keller JM, Beach MC, Anderson JR, Moore RD. HIV women's health: S study of gynecological healthcare service utilization in a U.S. urban clinic population. J Women's Health. 2008;17:1609-1614.
32. Baranoski AS, Horsburgh CR, Cupples LA, Aschengrau A, Stier EA. Risk factors for nonadherence with Pap testing in HIV-infected women. J Women's Health. 2011;20:1635-1643.
33. Wang PJ, Huang N, Chou YJ, Lee CH, Chang HJ. Determinants of the receipt of Pap smear screening under the National Health Insurance, a panel study during 1997-2000. Taiwan J Public Health. 2005;24:33-42.
34. Andrasik MP, Rose R, Pereira D, Antoni M. Barriers to cervical cancer screening among low-income HIV-positive African American women. J Health Care Poor Underserved. 2008;19:912-925.